TERAPET
Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.
TERAPET
Industry:
Health Care
Founded:
2019-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.terapet.ch
Total Employee:
1+
Status:
Active
Total Funding:
1.84 M USD
Technology used in webpage:
Euro IPv6 Hostpoint
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
First Ascent Biomedical
Personalized Cancer Therapy, Machine Learning/AI, Cancer Drug Combinations
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Pepgen
PepGen is empowering nucleic acid therapeutics to go the distance.
Scailyte
True precision medicine through single-cell science
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
Nina Capital
Nina Capital investment in Seed Round - Terapet
Venture Kick
Venture Kick investment in Grant - Terapet
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Terapet
MassChallenge
MassChallenge investment in Non Equity Assistance - Terapet
Official Site Inspections
http://www.terapet.ch
- Host name: sl1072.web.hostpoint.ch
- IP address: 217.26.61.158
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
